EPO and cancer: Consistent with the cancer cell viability data, in which SPO exhibited stronger cytotoxicity than EPO in SW620 cells, whereas EPO more effectively reduced cell viability in A375P cells, the iNOS results likewise showed that EPO suppressed iNOS expression more than SPO in A375P cells, while SPO produced greater inhibition than EPO in SW620 cells.